Walder Wyss advised Groupe Mutuel on this transaction. The team was led by Luc Defferrard (Partner, Corporate / M&A - pictured) and Rafael Zemp (Managing Associate, Corporate / M&A)
Tags :Rafael Zemp
Walder Wyss acted as Swiss counsel to CRISPR in connection with the transaction. The team was led by partner Alex Nikitine. Homburger acted as legal counsel to Goldman Sachs & Co. LLC, BofA Securities, Inc. and
The Switzerland-based pharmaceutical and healthcare company, Swixx Biopharma, has acquired Delta Medical, a Russia-based distributor of medical equipments.
